Barclays PLC Legend Biotech Corp Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Barclays PLC holds 160,350 shares of LEGN stock, worth $5.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,350
Previous 160,350
-0.0%
Holding current value
$5.44 Million
Previous $7.81 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$379 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$255 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$225 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$194 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$171 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.68B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...